Shanghai Haoyuan Chemexpress Co., Ltd. (SHA:688131)
83.37
+5.56 (7.15%)
Oct 28, 2026, 3:00 PM CST
SHA:688131 Market Cap
SHA:688131 has a market cap or net worth of 17.78 billion as of October 27, 2026. It is the 5,604th most valuable company in the world and the 927th biggest in China. Its market cap has decreased by 2.26% in one year.
Market Cap
17.78B
Enterprise Value
18.59B
Revenue
3.21B
Global Rank
Country Rank
#927 China
PE Ratio
68.34
ChartMarket Cap Chart
Since June 8, 2021, SHA:688131's market cap has decreased from 23.30B to 17.78B, a decrease of -23.71%. That is a compound annual growth rate of -4.89%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2026 | 17.78B | 16.28% |
| Dec 31, 2025 | 15.29B | 103.03% |
| Dec 31, 2024 | 7.53B | -3.82% |
| Dec 29, 2023 | 7.83B | -32.18% |
| Dec 30, 2022 | 11.54B | -37.56% |
| Dec 31, 2021 | 18.49B | -20.66% |
| Jun 8, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Tasly Pharmaceutical Group | 20.59B |
| Walvax Biotechnology | 20.31B |
| Jilin Aodong Pharmaceutical Group | 19.80B |
| Chengdu Kanghong Pharmaceutical Group | 18.38B |
| Betta Pharmaceuticals | 17.94B |
| Kangmei Pharmaceutical | 17.56B |
| Joincare Pharmaceutical Group Industry | 16.96B |
| China Resources Double-Crane Pharmaceutical | 16.52B |